Table 4 DenTiUS Deep Plaque clinical indices were obtained for test group B on day 4 (phase 1: receiving the placebo mouthwash) and day 8 (phase 2: receiving the cymenol mouthwash)
DenTiUS Deep Plaque clinical indices | Test group B | p-value | |
|---|---|---|---|
Phase 1_Day 4 (Mean % ± S.D.) | Phase 2_Day 8 (Mean % ± S.D.) | ||
Visible plaque area (absolute) | 46.57 ± 18.92 | 65.12 ± 16.37 | < 0.001 |
Visible plaque area (relative) | 40.53 ± 18.48 | 59.24 ± 16.90 | < 0.001 |
Total plaque area | 62.75 ± 16.85 | 74.52 ± 13.55 | < 0.001 |
Visible plaque area growth (absolute) | 0.49 ± 0.20 | 0.34 ± 0.08 | < 0.001 |
Visible plaque area growth (relative) | 0.43 ± 0.19 | 0.31 ± 0.08 | 0.001 |
Total plaque area growth | 0.67 ± 0.18 | 0.39 ± 0.07 | < 0.001 |